The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.
RAS AL KHAIMAH / WAM
Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, recorded sales of AED1.3 billion for the year ending December 31, 2017, despite the challenging and rapidly changing market environment.
The Gulf Pharmaceutical Industries Manufacturers reviewed non-audited preliminary financial results for 2017 and forecasts for 2018, following its Board of Directors’ meeting, which was chaired by Sheikh Faisal bin Saqr Al Qasimi, Chairman of the Board of Julphar.
Julphar’s General Manager, Jerome Carle, said, “Firstly, I wish to express my gratitude to the shareholders, colleagues, customers, partners and all the stakeholders of the company for their continued support. In 2017, Julphar faced major challenges, such as currency headwinds, forex shortage, political instability and price cuts.